Mixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use

Abstract

Background: Mixed depression (MxD) is narrowly defined in the DSM-IV and somewhat broader in the DSM-5, although both exclude psychomotor agitation as a diagnostic criterion. This article proposes a clinical description for defining MxD, which emphasizes psychomotor excitation. Methods: Two hundred and nineteen consecutive outpatients were diagnosed with an MxD episode using criteria proposed by Koukopoulos et al. [Acta Psychiatr Scand 2007;115(suppl 433):50-57]; we here report their clinical features and antidepressant-related effects. Results: The most frequent MxD symptoms were: psychic agitation or inner tension (97%), absence of retardation (82%), dramatic description of suffering or weeping spells (53%), talkativeness (49%), and racing or crowded thoughts (48%). MxD was associated with antidepressants in 50.7% of patients, with similar frequency for tricyclic antidepressants (45%) versus selective serotonin reuptake inhibitors (38.5%). Positive predictors of antidepressant-associated MxD were bipolar disorder type II diagnosis, higher index depression severity, and higher age at index episode. Antipsychotic or no treatment was protective against antidepressant-associated MxD. Conclusions: MxD, defined as depression with excitatory symptoms, can be clinically identified, is common, occurs in both unipolar depression and bipolar disorder, and is frequently associated with antidepressant use. If replicated, this view of MxD could be considered a valid alternative to the DSM-5 criteria for depression with mixed features.

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features

“…Nevertheless, the MDE-A patients treated with ADs showed significantly higher rates of AD-induced mania/hypomania compared with patients without aggressiveness, which represents another strong indicator of bipolarity (20,21,27,34,35,37,(42)(43)(44)(45).…”

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

“…Treatment with ADs has been associated with mania or other forms of excessive behavioral activation [169,170]. These responses may unveil unrecognized bipolar illness or may be drug induced since they may also occur in allegedly unipolar patients.…”

A Prospective Study on How Symptoms in a Network Predict the Onset of Depression

“…In addition, the presence of specific symptoms (e.g. psychomotor agitation) may have important clinical implications, such as expectations regarding the response to antidepressants [3]. …”